Cynata
An Australian clinical-stage stem cell and regenerative medicine company focused on the development of therapies based on a proprietary therapeutic stem cell platform technology.
Launch date
Employees
Market cap
€20.2m
Enterprise valuation
€17m (Public information from Sep 2024)
Share price
AUD0.21 CYP.AX
Melbourne Victoria (HQ)
Authorizing premium user...